Literature DB >> 2805617

Ankylosing spondylitis. An unusual manifestation of familial Mediterranean fever. Report of a case complicated by amyloidosis and polyneuropathy.

D C Knockaert1, I G Malysse, W E Peetermans.   

Abstract

We report a case of familial Mediterranean fever (FMF) with typical clinical and roentgenological findings of ankylosing spondylitis. The spinal involvement in FMF is discussed. A second unusual feature of this case is the occurrence of polyneuropathy which could possibly be ascribed to the slowly evolving amyloidosis during continuous colchicine treatment.

Entities:  

Mesh：

Year:  1989        PMID： 2805617     DOI： 10.1007/bf02030357

Source DB:  PubMed          Journal:  Clin Rheumatol        ISSN： 0770-3198            Impact factor:   2.980


  15 in total

1.  Radiographic changes in the sacroiliac joints in familial Mediterranean fever.

Authors:  P A Brodey; S M Wolff
Journal:  Radiology       Date:  1975-02       Impact factor: 11.105

2.  [Periodic disease].

Authors:  A Courillon-Mallet; M Dervichian; D Cattan
Journal:  Rev Prat       Date:  1986-04-21

Review 3.  Familial Mediterranean fever. A survey of 470 cases and review of the literature.

Authors:  E Sohar; J Gafni; M Pras; H Heller
Journal:  Am J Med       Date:  1967-08       Impact factor: 4.965

4.  [Severe muscular manifestations during periodic disease with ankylosing spondylitis. Effect of colchicine].

Authors:  B Delcambre; D Defrance; B Duquesnoy; J J Deremaux; J R d'Eshougues
Journal:  Rev Rhum Mal Osteoartic       Date:  1979 Jul-Sep

5.  [Ankylosing spondylitis and amyloidosis. Apropos of 2 cases].

Authors:  N Hajjaj-Hassouni; S Laghrissi; A Khalil; O Mkinsi; A Maaouni; A Berbich; A Tazi
Journal:  Rev Rhum Mal Osteoartic       Date:  1982-10

6.  HLA-B27-negative sacroiliitis: a manifestation of familial Mediterranean fever in childhood.

Authors:  T J Lehman; V Hanson; H Kornreich; R S Peters; A D Schwabe
Journal:  Pediatrics       Date:  1978-03       Impact factor: 7.124

Review 7.  Familial Mediterranean fever: report of a large family, review of the literature, and discussion of the frequency of amyloidosis.

Authors:  J Meyerhoff
Journal:  Medicine (Baltimore)       Date:  1980-01       Impact factor: 1.889

8.  Colchicine in the prevention and treatment of the amyloidosis of familial Mediterranean fever.

Authors:  D Zemer; M Pras; E Sohar; M Modan; S Cabili; J Gafni
Journal:  N Engl J Med       Date:  1986-04-17       Impact factor: 91.245

9.  Ten years' experience of an amyloid clinic--a clinicopathological survey.

Authors:  M J Browning; R A Banks; C R Tribe; P Hollingworth; C Kingswood; J C Mackenzie; P A Bacon
Journal:  Q J Med       Date:  1985-03

10.  The arthritis of familial Mediterranean fever (FMF).

Authors:  H Heller; J Gafni; D Michaeli; N Shahin; E Sohar; G Ehrlich; I Karten; L Sokoloff
Journal:  Arthritis Rheum       Date:  1966-02
View more
  4 in total

1.  Familial Mediterranean fever responds well to infliximab: single case experience.

Authors:  Salih Ozgocmen; Levent Ozçakar; Ozge Ardicoglu; Ercan Kocakoc; Arzu Kaya; Adem Kiris
Journal:  Clin Rheumatol       Date:  2005-09-20       Impact factor: 2.980

Review 2.  Familial Mediterranean fever and seronegative arthritis.

Authors:  Nurullah Akkoc; Ahmet Gul
Journal:  Curr Rheumatol Rep       Date:  2011-10       Impact factor: 4.592

3.  The rate and significance of Mediterranean fever gene mutations in patients with ankylosing spondylitis: a three-month, longitudinal clinical study.

Authors:  Muhammet Cinar; Ayhan Dinc; Ismail Simsek; Hakan Erdem; Bayram Koc; Salih Pay; Yusuf Tunca; Selim Kilic; Davud Gul
Journal:  Rheumatol Int       Date:  2008-07-03       Impact factor: 2.631

4.  FMF Is Associated With a Wide Spectrum of MHC Class I- and Allied SpA Disorders but Not With Classical MHC Class II-Associated Autoimmune Disease: Insights From a Large Cohort Study.

Authors:  Abdulla Watad; Nicola Luigi Bragazzi; Mohammad Adawi; Yehuda Shoenfeld; Doron Comaneshter; Arnon D Cohen; Dennis McGonagle; Howard Amital
Journal:  Front Immunol       Date:  2019-11-26       Impact factor: 7.561
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.